Axillary reverse mapping and lymphaticovenous bypass: Lymphedema prevention through enhanced lymphatic visualization and restoration of flow.


Journal

Journal of surgical oncology
ISSN: 1096-9098
Titre abrégé: J Surg Oncol
Pays: United States
ID NLM: 0222643

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 24 02 2019
revised: 27 04 2019
accepted: 03 05 2019
pubmed: 31 5 2019
medline: 20 7 2019
entrez: 31 5 2019
Statut: ppublish

Résumé

A lymphedema (LE) prevention surgery (LPS) paradigm for patients undergoing axillary lymphadenectomy (ALND) was developed to protect against LE through enhanced lymphatic visualization during axillary reverse mapping (ARM) and refinement in decision making during lymphaticovenous bypass (LVB). A retrospective analysis of a prospective database was performed evaluating patients with breast cancer who underwent ALND, ARM, and LVB from September 2016 to December 2018. Patient and tumor characteristics, oncologic and reconstructive operative details, complications and LE development were analyzed. LPS was completed in 58 patients with a mean age of 51.7 years. An average of 14 lymph nodes (LN) were removed during ALND. An average of 2.1 blue lymphatic channels were visualized with an average of 1.4 LVBs performed per patient. End to end anastomosis was performed in 37 patients and a multiple lymphatic intussusception technique in 21. Patency was confirmed 96.5% of patients. Adjuvant radiation was administered to 89% of patients. Two patients developed LE with a median follow-up of 11.8 months. We report on our experience using a unique LPS technique. Refinements in ARM and a systematic approach to LVB allows for maximal preservation of lymphatic continuity, identification of transected lymphatics, and reestablishment of upper extremity lymphatic drainage pathways.

Sections du résumé

BACKGROUND BACKGROUND
A lymphedema (LE) prevention surgery (LPS) paradigm for patients undergoing axillary lymphadenectomy (ALND) was developed to protect against LE through enhanced lymphatic visualization during axillary reverse mapping (ARM) and refinement in decision making during lymphaticovenous bypass (LVB).
METHODS METHODS
A retrospective analysis of a prospective database was performed evaluating patients with breast cancer who underwent ALND, ARM, and LVB from September 2016 to December 2018. Patient and tumor characteristics, oncologic and reconstructive operative details, complications and LE development were analyzed.
RESULTS RESULTS
LPS was completed in 58 patients with a mean age of 51.7 years. An average of 14 lymph nodes (LN) were removed during ALND. An average of 2.1 blue lymphatic channels were visualized with an average of 1.4 LVBs performed per patient. End to end anastomosis was performed in 37 patients and a multiple lymphatic intussusception technique in 21. Patency was confirmed 96.5% of patients. Adjuvant radiation was administered to 89% of patients. Two patients developed LE with a median follow-up of 11.8 months.
CONCLUSION CONCLUSIONS
We report on our experience using a unique LPS technique. Refinements in ARM and a systematic approach to LVB allows for maximal preservation of lymphatic continuity, identification of transected lymphatics, and reestablishment of upper extremity lymphatic drainage pathways.

Identifiants

pubmed: 31144329
doi: 10.1002/jso.25513
doi:

Substances chimiques

Coloring Agents 0
Indocyanine Green IX6J1063HV

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

160-167

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Graham S Schwarz (GS)

Department of Plastic Surgery, Cleveland Clinic, Cleveland, Ohio.

Stephen R Grobmyer (SR)

Department of General Surgery, Division of Breast Surgery, Cleveland Clinic, Cleveland, Ohio.

Risal S Djohan (RS)

Department of Plastic Surgery, Cleveland Clinic, Cleveland, Ohio.

Cagri Cakmakoglu (C)

Department of Plastic Surgery, Cleveland Clinic, Cleveland, Ohio.

Steven L Bernard (SL)

Department of Plastic Surgery, Cleveland Clinic, Cleveland, Ohio.

Diane Radford (D)

Department of General Surgery, Division of Breast Surgery, Cleveland Clinic, Cleveland, Ohio.

Zahraa Al-Hilli (Z)

Department of General Surgery, Division of Breast Surgery, Cleveland Clinic, Cleveland, Ohio.

Rebecca Knackstedt (R)

Department of Plastic Surgery, Cleveland Clinic, Cleveland, Ohio.

Michelle Djohan (M)

Department of Plastic Surgery, Cleveland Clinic, Cleveland, Ohio.

Stephanie A Valente (SA)

Department of General Surgery, Division of Breast Surgery, Cleveland Clinic, Cleveland, Ohio.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH